FIELD: medicine.
SUBSTANCE: invention relates to medicine. Disclosed are methods and use of CETP inhibitor, namely, dalcetrapib, for treating a subject with acute coronary syndrome, where the subject has nucleotide polymorphisms in the gene of adenylate cyclase type 9 (ADCY9) in chromosome 16. There are also presented methods and applications of dalcetrapib in the preparation of a drug for treating a subject with acute coronary syndrome and for reducing the risk of a cardiovascular event.
EFFECT: subject genotyping according to the present invention can find further application in treating cardiovascular diseases and in predicting response to such treatment.
30 cl, 8 dwg, 8 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
GENETIC MARKERS FOR PREDICTING SENSITIVITY TO THERAPY | 2014 |
|
RU2809215C2 |
GENETIC MARKERS FOR PREDICTING RESPONSE TO THERAPY BY RAISING HDL LEVEL OR IMITATING HDL AGENTS | 2015 |
|
RU2703192C2 |
METHOD OF FINDING PRONENESS TO HIGH-ALTITUDE PULMONARY EDEMA | 2003 |
|
RU2353656C2 |
ANALYSIS AND METHOD FOR TREATMENT REGIMEN SELECTION FOR PATIENTS WITH DEPRESSION | 2012 |
|
RU2622082C2 |
RISK MARKERS FOR CARDIOVASCULAR DISEASES IN PATIENTS WITH CHRONIC KIDNEY DISEASE | 2014 |
|
RU2656148C2 |
METHODS FOR SELECTIVE TREATMENT OF ASTHMA USING IL-13 ANTAGONISTS | 2015 |
|
RU2694980C2 |
INTROGRESSION OF TWO QTL OF FRUIT YIELD IN CUCUMIS SATIVUS PLANTS | 2017 |
|
RU2746936C2 |
QTL OF CROP IN CUCUMBER PLANTS | 2015 |
|
RU2723586C2 |
QTL OF CROP IN CUCUMBER PLANTS | 2015 |
|
RU2723581C2 |
METHODS AND COMPOSITIONS FOR PREDICTION OF THERAPEUTIC EFFICIENCY OF TREATMENT OF ONCOLOGICAL DISEASES AND PREDICTION OF ONCOLOGICAL DISEASES | 2016 |
|
RU2785291C2 |
Authors
Dates
2019-11-27—Published
2014-03-24—Filed